title: The NADase-Negative Variant of the Streptococcus pyogenes Toxin NAD⁺ Glycohydrolase Induces JNK1-Mediated Programmed Cellular Necrosis.
abstract: Virulence factors are often multifunctional and contribute to pathogenesis through synergistic mechanisms. For the human pathogen Streptococcus pyogenes, two factors that act synergistically are the S. pyogenes NAD(+) glycohydrolase (SPN) and streptolysin O (SLO). Through distinct mechanisms, SLO forms pores in host cell membranes and translocates SPN into the host cell cytosol. Two natural variants of SPN exist, one that exhibits NADase activity and one that lacks this function, and both versions are translocated and act in concert with SLO to cause an accelerated death response in epithelial cells. While NADase(+) SPN is known to trigger a metabolic form of necrosis through the depletion of NAD(+), the mechanism by which NADase(-) SPN induces cell death was unknown. In the studies described here, we examined the pathway of NADase(-) cell death through analysis of activation patterns of mitogen-activated protein kinases (MAPKs). S. pyogenes infection resulted in activation of members of three MAPK subfamilies (p38, ERK, and JNK). However, only JNK was activated in an SLO-specific manner. NADase(-) SPN induced necrosis in HeLa epithelial cells associated with depolarization of mitochondrial membranes, activation of NF-κB, and the generation of reactive oxygen species. Remarkably, RNA interference (RNAi) silencing of JNK protected cells from NADase(-)-SPN-mediated necrosis, suggesting that NADase(-) SPN triggers a form of programmed necrosis dependent on JNK signaling. Taken together, these data demonstrate that SPN acts with SLO to elicit necrosis through two different mechanisms depending on its NADase activity, i.e., metabolic (NADase(+)) or programmed (NADase(-)), leading to distinct inflammatory profiles.
  
  
  OBJECTIVE
  Many bacterial pathogens produce toxins that alter how infected host cells interact with the immune system. For Streptococcus pyogenes, two toxins, a NAD(+) glycohydrolase (SPN) and streptolysin O (SLO), act in combination to cause infected cells to die. However, there are two natural forms of SPN, and these variants cause dying cells to produce different types of signaling molecules. The NADase(+) form of SPN kills cells by depleting reserves of NAD(+) and cellular energy. The other form of SPN lacks this activity (NADase(-)); thus, the mechanism by which this variant induces toxicity was unknown. Here, we show that infected cells recognize NADase(-) SPN through a specific signaling molecule called JNK, which causes these cells to undergo a form of cellular suicide known as programmed necrosis. This helps us to understand how different forms of toxins alter host cell signaling to help S. pyogenes cause different types of diseases.
authors.affiliation: Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA.
authors.forename: Sukantha
authors.initials: S
authors.lastname: Chandrasekaran
authors.affiliation: Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA caparon@wusm.wustl.edu.
authors.forename: Michael G
authors.initials: MG
authors.lastname: Caparon
mesh_terms: D001427:Bacterial Toxins / Q000378:metabolism*; D016923:Cell Death; D004847:Epithelial Cells / Q000382:microbiology* / Q000502:physiology*; D006367:HeLa Cells; D006801:Humans; D048055:Mitogen-Activated Protein Kinase 8 / Q000378:metabolism*; D009244:NAD+ Nucleosidase / Q000172:deficiency / Q000378:metabolism*; D015398:Signal Transduction; D013297:Streptococcus pyogenes / Q000472:pathogenicity*
chemical_list: D001427:Bacterial Toxins; D048055:Mitogen-Activated Protein Kinase 8; D009244:NAD+ Nucleosidase
references.citation: Cell Microbiol. 2015 Sep;17(9):1376-90
references.pmid: 25818652
references.citation: J Biol Chem. 2006 Mar 31;281(13):8788-95
references.pmid: 16446354
references.citation: PLoS Pathog. 2013;9(6):e1003394
references.pmid: 23762025
references.citation: Clin Microbiol Rev. 2014 Apr;27(2):264-301
references.pmid: 24696436
references.citation: Cell Death Differ. 2006 May;13(5):712-29
references.pmid: 16456579
references.citation: Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):10995-1000
references.pmid: 15256590
references.citation: J Biol Chem. 2010 Feb 19;285(8):5683-94
references.pmid: 20018886
references.citation: Nat Rev Mol Cell Biol. 2010 Oct;11(10):700-14
references.pmid: 20823910
references.citation: J Biol Chem. 2006 May 5;281(18):12994-8
references.pmid: 16520379
references.citation: Biochem Biophys Res Commun. 2006 Jun 16;344(4):1128-34
references.pmid: 16643845
references.citation: MBio. 2014;5(5):e01690-14
references.pmid: 25227466
references.citation: Microbiol Mol Biol Rev. 2013 Jun;77(2):173-207
references.pmid: 23699254
references.citation: Cell Microbiol. 2005 Jul;7(7):945-55
references.pmid: 15953027
references.citation: Nat Struct Mol Biol. 2015 Sep;22(9):672-8
references.pmid: 26237511
references.citation: EMBO Rep. 2010 May;11(5):400-5
references.pmid: 20339385
references.citation: Oncogene. 2001 Jun 7;20(26):3354-62
references.pmid: 11423986
references.citation: J Biol Chem. 2011 May 6;286(18):16052-62
references.pmid: 21454558
references.citation: Mol Microbiol. 2014 Nov;94(3):675-87
references.pmid: 25196983
references.citation: Biochemistry. 1998 Oct 13;37(41):14563-74
references.pmid: 9772185
references.citation: J Biol Chem. 2013 Jul 5;288(27):20064-75
references.pmid: 23689507
references.citation: Mol Microbiol. 2006 Nov;62(4):1203-14
references.pmid: 17042787
references.citation: Cell Death Differ. 2007 May;14(5):1001-10
references.pmid: 17218956
references.citation: ACS Chem Biol. 2011 Aug 19;6(8):808-18
references.pmid: 21563797
references.citation: J Biol Chem. 2013 Feb 8;288(6):4000-11
references.pmid: 23258542
references.citation: Cell Microbiol. 2014 Nov;16(11):1678-92
references.pmid: 24898616
references.citation: Cell. 2005 Mar 11;120(5):649-61
references.pmid: 15766528
references.citation: Cell. 2004 Nov 12;119(4):529-42
references.pmid: 15537542
references.citation: BMC Cancer. 2014;14:640
references.pmid: 25175743
references.citation: Clin Microbiol Rev. 2000 Jul;13(3):470-511
references.pmid: 10885988
references.citation: Genome Announc. 2015 Jul 02;3(4):null
references.pmid: 26139722
references.citation: J Am Acad Child Adolesc Psychiatry. 2011 Feb;50(2):108-118.e3
references.pmid: 21241948
references.citation: Infect Immun. 2003 Nov;71(11):6171-7
references.pmid: 14573633
references.citation: Cell. 2001 Jan 12;104(1):143-52
references.pmid: 11163247
references.citation: J Bacteriol. 2010 Jul;192(14):3735-46
references.pmid: 20494994
references.citation: Genes Dev. 2004 Dec 1;18(23):2905-15
references.pmid: 15545623
references.citation: Infect Immun. 2005 Apr;73(4):1907-16
references.pmid: 15784530
references.citation: J Biol Chem. 2006 Mar 24;281(12):8216-23
references.pmid: 16431917
references.citation: EMBO Rep. 2001 Mar;2(3):222-8
references.pmid: 11266364
references.citation: J Cell Sci. 2007 Feb 1;120(Pt 3):379-83
references.pmid: 17251378
references.citation: Biochem Biophys Res Commun. 2009 Aug 7;385(4):503-6
references.pmid: 19497299
references.citation: Mol Microbiol. 2015 Sep;97(6):1036-50
references.pmid: 26059530
references.citation: Mol Aspects Med. 2013 Dec;34(6):1153-67
references.pmid: 23416893
references.citation: PLoS Pathog. 2011 Mar;7(3):e1001314
references.pmid: 21408619
references.citation: Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18674-9
references.pmid: 24167244